Skip to main content

Table 3 Single nucleotide polymorphisms in association with the phenotype “MTX intolerance”

From: Single nucleotide polymorphisms associated with methotrexate-induced nausea in juvenile idiopathic arthritis

 

Gene

SNP

Alleles, Major > minor

MTXintolerant1 Allel count

MTXtolerant Allel count

OR (95% CI)

p

Chr.

Genomic position

Consequence

Hepatic

ABCC2

rs2273697

G > A

36

22

1.05 (0.61–1.80)

0.87

10

99,804,058

Missense

Efflux

ABCC2

rs37400662

G > A

58

35

1.15 (0.64–2.07)

0.64

10

99,844,450

Missense

Transporter

ABCC2

rs717620

G > A

29

23

0.77 (0.42–1.41)

0.40

10

99,782,821

5’UTR variant

ABCB1

rs2032582

G > T

61

34

1.28 (0.73–2.24)

0.39

7

87,531,302

Missense

G > A

3

2

0.96 (0.15–5.96)

0.96

ABCB1

rs1045642

T > C

62

42

0.88 (0.49–1.57)

0.67

7

87,509,329

Synonymous

Hepatic

SLCO1B1

rs4149056

T > C

25

13

1.28 (0.62–2.66)

0.51

12

21,178,615

Missense

Influx

SLCO1B1

rs4149081

G > A

27

15

1.19 (0.59–2.43)

0.62

12

21,225,087

Intron variant

Transporter

SLCO1B3

rs2117032

T > C

52

34

0.97 (0.57–1.64)

0.90

12

20,921,188

Down stream 3’UTR

SLC19A1

rs10512662

G > A

64

38

1.20 (0.67–2.13)

0.54

21

45,537,880

Missense

Nausea

HTR3A

rs1062613

C > T

20

20

0.55 (0.27–1.14)

0.11

11

113,975,284

5’UTR variant

Receptor

HTR3A

rs1985242

T > A

36

32

0.58 (0.31–1.09)

0.09

11

113,977,551

5’UTR variant

HTR3A

rs1176713

T > C

27

22

0.74 (0.40–1.39)

0.35

11

113,989,703

Synonymous

HTR3B

rs1176744

T > G

52

27

1.36 (0.78–2.54)

0.26

11

113,932,306

Missense

MTHFR

MTHFR

rs18011312

A > C

44

34

0.77 (0.44–1.33)

0.35

1

11,794,419

Missense

Enzyme

MTHFR

rs1801133

C > T

49

21

1.77 (0.96–3.28)

0.07

1

11,796,321

Missense

  1. The additive effect of the minor allele on parent-assessed MTX-induced nausea – the methotrexate intolerance severity score. Listed for every single nucleotide polymorphism (SNP) are the respective gene, the alleles, the relevant chromosome (Chr.), the genomic position, and the consequence of the SNP
  2. N = 118, due to missing SNP data for two patients and MISS data for one
  3. OR Odds Ratio
  4. 1The MTXintolerant subgroup: children with a total score of the Methotrexate Intolerance Severity Score (MISS) ≥6 and at least 1 point in the anticipatory and/or associative and/or behavioral symptoms (n = 72). Otherwise categorised as MTXtolerant (n = 46)
  5. 2SNP variant not available for one child